Summary of top read business stories July 26 to 31


However, Malaysia University of Science and Technology or MUST professor Dr Geoffrey Williams believes Malaysia will see a long-haul recovery.

Top read stories include AstraZenecca, Pos Malaysia, AIA Malaysia and TNG Digital, Silterra, National Recovery Plan, food delivery platforms

AstraZeneca's Covid-19 shot did not increase the instances of rare blood clots with low platelets in people after the second dose, a study showed on Wednesday, potentially easing some worries over the vaccine's side-effects.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Oil rises on tighter OPEC supply, US jobs data
Gold inches lower as US yields, dollar rise on strong data
Bank Negara international reserves fall to US$116.2bil
Lim Seong Hai, Fibromat secure approval for listing transfer to ACE Market
Asian stocks slip, dollar boosted by US rate outlook
Chinese yuan to stay resilient, rebound despite headwinds
Oil rises on tighter Opec supply, US jobs data
Reservoir Link Energy's associate bags RM20mil floating solar farm project
Pantech Global inks IPO underwriting deal with Alliance Islamic Bank
HSS Engineers' consortium wins contract for LSS PV plant in Perak

Others Also Read